SU83096A1 - The method of treatment of degenerative conditions - Google Patents
The method of treatment of degenerative conditionsInfo
- Publication number
- SU83096A1 SU83096A1 SU890022A SU890022A SU83096A1 SU 83096 A1 SU83096 A1 SU 83096A1 SU 890022 A SU890022 A SU 890022A SU 890022 A SU890022 A SU 890022A SU 83096 A1 SU83096 A1 SU 83096A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- degenerative conditions
- conditions
- dystrophic
- degenerative
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Предмет1)м изобретений нн. .:i)(.cn6 ,чечени дистрофических состо ний.Subject1) m inventions nn. .: i) (. cn6, chechen dystrophic conditions.
Известны многие опосоод :-; лечеиии различного рода дистроф ческих состо ний, в ТОЛ числе U лечение аминокислотами, вводимыми в организм через желудочно-кишечный тракт.Many known posozods: -; treatment of various types of dystrophic conditions, including TOL, treatment of amino acids introduced into the body through the gastrointestinal tract.
Отличительной 1)собеннос7 ю лред.чагаемого способа лечени дистрофическ :х состо ний вл етсй то, что продукты кислотного гидоолнза очищенного казенна («аминссп нлгулин) ввод т внутривенно.Distinctive 1) The characteristic of the treatment of dystrophic conditions is that the acidic acid products of the clean state ("Aminssp Nlgulin") are administered intravenously.
Такой снособ лечени CTHAiyjjHpytT клетки и ткани человеческого организма в нанравлении синтеза собственного белка.This method of treatment of CTHAiyjjHpytT cells and human tissues in the treatment of the synthesis of its own protein.
Снособ лечени дистрофических состо ниГ заключаетс в следую .це.1.A method for treating dystrophic conditions of niG is as follows.
Больно:му В 3од т в-нутрИЕсино по 2 см аминостИМЗли на ежедневно в течение, приблизительно, двух недель.It hurts: Mu In 3od t in-thirds of 2 cm aminostimum per day for about two weeks.
Предмет изобретени Subject invention
Способ лечени диетрофических состо ний, отличающийс тем. что продукты кислотного гиднолиз очищенного казеина («амнностимулин ) ввод т внутривенно.A method for the treatment of nutritional conditions characterized in that. that the products of acid hydrolysis of purified casein ("amnostimulin") are administered intravenously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU890022A SU83096A1 (en) | 1949-01-11 | 1949-01-11 | The method of treatment of degenerative conditions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU890022A SU83096A1 (en) | 1949-01-11 | 1949-01-11 | The method of treatment of degenerative conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU83096A1 true SU83096A1 (en) | 1949-11-30 |
Family
ID=48256109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU890022A SU83096A1 (en) | 1949-01-11 | 1949-01-11 | The method of treatment of degenerative conditions |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU83096A1 (en) |
-
1949
- 1949-01-11 SU SU890022A patent/SU83096A1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagpal et al. | Bioactive peptides derived from milk proteins and their health beneficial potentials: an update | |
| Du Vigneaud et al. | The synthesis of oxytocin1 | |
| DE69532760T2 (en) | AGENTS FOR THE ADMINISTRATION OF ANTIGENS | |
| JP5247429B2 (en) | Pharmaceutical composition containing casein-derived peptide and method of using the same | |
| ES424434A1 (en) | Methods and compositions for inhibiting rumen microbial deamination | |
| JP2008174561A (en) | Colostrinin and its use | |
| US7253143B1 (en) | Peptides based on the sequence of human lactoferrin and their use | |
| JPS5692850A (en) | Acylpeptide* its manufacture and medicinal medicine containing it | |
| FR2453650A1 (en) | MEDICAMENT BASED ON CHOLECALCIFEROL DERIVATIVES, USEFUL FOR ADJUSTING BONE METABOLISM IN HOMEOTHERMES | |
| WO2017009486A1 (en) | Topical compositions | |
| SU83096A1 (en) | The method of treatment of degenerative conditions | |
| EA035808B1 (en) | Therapeutically active pentadecapeptide salt stable at the influence of temperature, humidity and gastric juice, process for preparation and use thereof | |
| Rhoads et al. | The absorption of protein split products from chronic isolated colon loops | |
| JP2015516377A (en) | Peptides for the management of lactation | |
| ATE72120T1 (en) | USE OF PETASITES EXTRACTS IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES. | |
| US3904754A (en) | Therapeutic compositions containing lipopoly (alpha-amino acids) | |
| WO2018014936A1 (en) | Topical compositions | |
| GB1160151A (en) | Therapeutically Active Metal Chelates of Proteins | |
| JP2657515B2 (en) | Skin cosmetics and method for producing the same | |
| JPH08143468A (en) | Antiulcer agent | |
| JPS649938A (en) | Oral ingestive composition | |
| JPH05255109A (en) | Antibacterial agent and treating method for article using the same | |
| GB1392241A (en) | Antibacterial agents and a process for the preparation thereof | |
| JP2873434B2 (en) | New peptides and immunostimulants | |
| Sharpless et al. | Choline and pyridoxine as factors in prevention of epithelial hyperplasia in the forestomach of rats fed white flour |